These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 16239090

  • 1. [Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis].
    Perronne C, Drugeon H, Zuck P, Filipecki J, Vincent-Lacaze N, Goldfarb G, Léophonte P.
    Med Mal Infect; 2005 Oct; 35(10):507-15. PubMed ID: 16239090
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P, Dobryniewska M, Busman T, Notario G.
    Curr Med Res Opin; 2003 Oct; 19(5):411-20. PubMed ID: 13678478
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
    Quinn J, Ruoff GE, Ziter PS.
    Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
    Niederman MS, Chang JR, Stewart J, Asche CV, Lavin B, Nusrat R, Sullivan SD.
    Curr Med Res Opin; 2004 Jul; 20(7):969-80. PubMed ID: 15265241
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and tolerability of extended-release clarithromycin.
    Guay DR, Gustavson LE, Devcich KJ, Zhang J, Cao G, Olson CA.
    Clin Ther; 2001 Apr; 23(4):566-77. PubMed ID: 11354390
    [Abstract] [Full Text] [Related]

  • 16. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
    Niederman MS, Chang JR, Stewart J, Nusrat R, Nieman RB.
    Curr Med Res Opin; 2004 May; 20(5):749-56. PubMed ID: 15140342
    [Abstract] [Full Text] [Related]

  • 17. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
    Takker U, Dzyublyk O, Busman T, Notario G.
    Curr Med Res Opin; 2003 May; 19(5):421-9. PubMed ID: 13678479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.